Established TAVR Platforms Evolving for Lifetime Management
New additions to Sapien, Evolut, Navitor lines aim to ensure coronary access
Source: medpagetoday.com
📰 Bassem Chehab News
Bassem Chehab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bassem Chehab. Real-time updates on events, politics, business and more.
Via Christi conducts trial on new heart procedure
The Structural Heart Team at Via Christi has successfully completed the first four cases of a new clinical trial of a new heart procedure.
Brett Grizzell Bassem Chehab Structural Heart Team At Via Christi Structural Heart Team Via Christi Acute Decompensated Heart
Source: yahoo.com
Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix Percutaneous Mechanical Circulatory Support Technology
Technology to be evaluated in acute decompensated heart failure patients, where current treatment options remain ineffective and lacking
United States Erics Fain Bassem Chehab Gillian Grafton Procyrion Inc Journal Of The American College Cardiology
Source: dicardiology.com
Procyrion enrolls first patient in mechanical circulatory support trial
Procyrion announced today that it enrolled the first patient in its investigational device exemption trial of the Aortix system.
United States Gillian Grafton Bassem Chehab Erics Fain Procyrion Aortix Ascension Via Christi Hospital
Source: massdevice.com
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference News provided by Share this article Share this article IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the companys strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance today during its annual investor conference. Highlights Presenting long-term strategic initiatives and growth outlook Projecting 2021 global...
Source: prnewswire.com